In areas with a high incidence of PCa, in high-risk populations, or when mpMRI is not available, it is recommended to use a threshold of 62, which has 89.0% specificity, and to combine it with PSA to avoid unnecessary biopsies or MRI. This evidence concerns the gene KLK3 and posterior cortical atrophy.